Mechanisms of non-apoptotic programmed cell death and corpse clearance
Mechanisms of non-apoptotic programmed cell death and corpse clearance
批准号:
10292225
负责人:
Ann M Wehman
金额:
$43.61万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-08-01 至 2024-07-31
关键词:
Antigen PresentationApoptosisAutoimmune DiseasesCaenorhabditis elegansCaspaseCell DeathCellsCessation of lifeDataDefectDevelopmentDiseaseGenetic ModelsGoalsHealthHomeostasisHumanImmuneImmune System DiseasesImmune signalingInflammationKnowledgeLeadLipidsMHC Class II GenesMalignant NeoplasmsMammalsMembraneModalityMolecularMutateNecrosisNucleic AcidsPathway interactionsPhagocytosisPhagolysosomePhagosomesPhosphatidylserinesPhysiologyProcessProtein FamilyProteinsRegulationResearchResistanceRoleSignal PathwaySignal TransductionWorkbaseblastomere structurecancer cellcell typedesigninsightpathogenrecruitrefractory cancerundergraduate student
中文摘要
非凋亡性细胞程序性死亡和身体清除的机制
项目摘要/摘要
许多细胞被编程为在发育和动态平衡期间死亡,但并不是所有的细胞都通过
细胞凋亡。此外,癌细胞已被证明对促进凋亡的疗法具有抵抗力。因此,它是
重要的是要了解细胞死亡的非凋亡机制,以及死亡细胞如何发出清除信号。
此外,身体清除和吞噬酶体降解对于避免炎症和自体感染也很重要。
免疫疾病,但我们对所有这些过程的理解存在重大差距。
我们确定线虫极体是非凋亡性细胞,经历一种未知形式的
程序性坏死(Fazeli等人,Cell Rep 2018)1。使用这个遗传模型,我们建议识别
在AIM 1中,导致坏死性细胞死亡和膜完整性丧失的机制,最初侧重于非
基于一名本科生产生的初步数据的凋亡半胱氨酸酶和扰乱酶调节因子
学生。这些有针对性的筛查将确定极体死亡是否与
已建立的程序性坏死模式或定义了一种未被发现的细胞死亡类型,这可能提供了洞察力
人类在健康和疾病期间的不明细胞死亡模式。
我们发现极体外化磷脂酰丝氨酸(PS),并被胚胎细胞用
与LC3相关的吞噬作用。然而,在坏死细胞中调节PS暴露的信号通路是
不知道。在一名本科生的初步数据中,我们发现了至少四种多余的脂肪
PS暴露所需的扰乱酶,并通过全部突变来减少PS暴露。这
方法是目标2中的几个方法之一,它将允许我们定义调节吞噬的信号通路
以及Atg8/Lc3家族蛋白被募集到吞噬小体中。这些信号通路
在其他类型的细胞死亡中可能是保守的,包括凋亡,提供了对
清理身体的机制。
我们还发现了ATG8/LC3招募到吞噬溶酶体的第一个作用:促进分解
管腔内的尸膜。然而,Atg8/LC3如何传递信号以及哪些因素
进行膜破裂仍然是一个谜。在目标3中,我们梳理了
Atg8/Lc3蛋白及其相互作用蛋白在确定身体膜破裂机制中的作用
噬菌体。膜破裂是核酸和蛋白质降解的限制因素
在吞噬小体内,这对表达MHC II类的免疫细胞尤其重要,其中
溶酶体分解产物用于抗原呈递。Lc3相关吞噬功能的AS缺陷
与哺乳动物的自身免疫性疾病有关,这决定了线虫细胞如何促进身体
膜破裂可以为人类免疫过程中的保守机制提供新的见解
除病原体清除外,信号、炎症和自身免疫性疾病。
英文摘要
Mechanisms of non-apoptotic programmed cell death and corpse clearance
Project Summary/Abstract
Many cells are programmed to die during development and homeostasis, but not all cells die via
apoptosis. Additionally, cancer cells have proven resistant to apoptosis-promoting therapies. Therefore, it is
important to understand non-apoptotic mechanisms of cell death, as well as how dying cells signal for clearance.
Furthermore, corpse clearance and phagolysosomal degradation are important to avoid inflammation and auto-
immune disease, but there are major gaps in our understanding of all these processes.
We established that C. elegans polar bodies are non-apoptotic cells that undergo an unknown form of
programmed necrosis(Fazeli et al., Cell Rep 2018)1. Using this genetic model, we propose to identify the
mechanisms that lead to necrotic cell death and loss of membrane integrity in Aim 1, focusing initially on non-
apoptotic caspases and scramblase regulators based on preliminary data generated by an undergraduate
student. These targeted screens will identify whether polar body death shares common mechanisms with
established modes of programmed necrosis or defines an undiscovered type of cell death, which may give insight
into uncharacterized cell death modalities in humans during health and disease.
We found that polar bodies externalize phosphatidylserine (PS) and are cleared by embryonic cells using
LC3-associated phagocytosis1. However, the signaling pathways that regulate PS exposure in necrotic cells are
not known. In preliminary data from an undergraduate student, we have identified at least four redundant lipid
scramblases that are required for PS exposure and have reduced PS exposure by mutating them all. This
approach is one of several in Aim 2 that will allow us to define the signaling pathways that regulate engulfment
of the corpse as well as the recruitment of Atg8/LC3 family proteins to the phagosome. These signaling pathways
may be conserved in other types of cell death, including apoptosis, providing wide-ranging insights into the
mechanisms of corpse clearance.
We also discovered the first role for Atg8/LC3 recruitment to the phagolysosome: promoting breakdown
of the corpse membrane within the lumen1. However, how Atg8/LC3 transduces the signal and which factors
carry out membrane breakdown remain a mystery. In Aim 3, we tease apart the localization and roles of
Atg8/LC3 proteins and their interactors to define the mechanisms of corpse membrane breakdown within the
phagolysosome. Membrane breakdown is the limiting factor for the degradation of nucleic acids and proteins
within phagolysosomal cargos, which is especially important for MHC class II-expressing immune cells, where
lysosomal breakdown products are used for antigen presentation. As defects in LC3-associated phagocytosis
have been tied to autoimmune disease in mammals, determining how C. elegans cells promote corpse
membrane breakdown can provide new insights into conserved mechanisms in humans during immune
signaling, inflammation, and autoimmune disease in addition to pathogen clearance.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Visualizing Phagocytic Cargo In Vivo from Engulfment to Resolution in Caenorhabditis elegans.
可视化秀丽隐杆线虫体内吞噬细胞从吞噬到溶解的过程。
DOI:
10.1007/978-1-0716-3338-0_22
发表时间:
2023
期刊:
Methods in molecular biology (Clifton, N.J.)
影响因子:
--
作者:
[Fazeli,Gholamreza, Frondoni,Julia, Kolli,Shruti, Wehman,AnnM]
通讯作者:
Wehman,AnnM
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: